GLOW Prices

GLOW is a marketed COMBINATION (blend), not a single peptide: a fixed ratio of BPC-157, TB-500, and GHK-Cu sold for skin rejuvenation and tissue repair.

Its effects come from the individual components, BPC-157 (anti-inflammatory/repair), TB-500 (angiogenesis), GHK-Cu (collagen/elastin), and there is little formal research on the fixed-ratio blend itself.

None of the components is FDA-approved; the strongest component evidence (GHK-Cu skin effects) is largely topical, and BPC-157/TB-500 data is overwhelmingly preclinical.

PeptidePrices safety rating

8/10 · Not FDA-approved (blend)

Mechanism

Fixed-ratio combination of three regenerative peptides: BPC-157 (anti-inflammatory, tissue repair), TB-500 (angiogenesis and cell migration), and GHK-Cu (collagen/elastin synthesis, copper delivery). Effects derive from the individual components rather than any proven synergy.

Research areas

Skin rejuvenation; anti-aging; collagen support; tissue repair; marketed as a single-injection regenerative blend.

Regulatory / research status

Research / preclinical only

Half-life

Varies by component (GHK-Cu ~minutes, BPC-157 ~4 hours, TB-500 long); a blend has no single half-life.

Storage

Lyophilized vial: store at -20°C long-term or 2-8°C short-term, protected from light.

Reported side effects

Injection-site reactions; temporary blue-green skin discoloration (copper); water retention; the main risk is overdosing an individual component in a fixed-ratio blend. Research-use only; not for human consumption.